550 related articles for article (PubMed ID: 28854594)
1. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
D'Hooghe T
Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
[TBL] [Abstract][Full Text] [Related]
2. Public welfare agenda or corporate research agenda?
Singh A; Singh S
Mens Sana Monogr; 2005 Mar; 3(1):41-80. PubMed ID: 22679348
[TBL] [Abstract][Full Text] [Related]
3. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment.
Baronikova S; Purvis J; Southam E; Beeso J; Panayi A; Winchester C
BMJ Evid Based Med; 2019 Oct; 24(5):177-184. PubMed ID: 30898790
[TBL] [Abstract][Full Text] [Related]
4. Food for thought? Potential conflicts of interest in academic experts advising government and charities on dietary policies.
Newton A; Lloyd-Williams F; Bromley H; Capewell S
BMC Public Health; 2016 Aug; 16():735. PubMed ID: 27495802
[TBL] [Abstract][Full Text] [Related]
5. The connection between academia and industry.
Singh A; Singh S
Mens Sana Monogr; 2005 Mar; 3(1):5-35. PubMed ID: 22679346
[TBL] [Abstract][Full Text] [Related]
6. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
Choudhry NK; Stelfox HT; Detsky AS
JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700
[TBL] [Abstract][Full Text] [Related]
7. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
8. Scientific journals and their authors' financial interests: a pilot study.
Krimsky S; Rothenberg LS; Stott P; Kyle G
Psychother Psychosom; 1998; 67(4-5):194-201. PubMed ID: 9693346
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials integrity: a CRO perspective.
Beach JE
Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
12. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
Ekimoto H
Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
[TBL] [Abstract][Full Text] [Related]
13. Ethical pharmaceutical promotion and communications worldwide: codes and regulations.
Francer J; Izquierdo JZ; Music T; Narsai K; Nikidis C; Simmonds H; Woods P
Philos Ethics Humanit Med; 2014 Mar; 9():7. PubMed ID: 24679064
[TBL] [Abstract][Full Text] [Related]
14. [Historical sketch of modern pharmaceutical science and technology (Part 4). Post World War II 50 years].
Yamakawa K
Yakushigaku Zasshi; 1995; 30(2):75-90. PubMed ID: 11613536
[TBL] [Abstract][Full Text] [Related]
15. Conflicts of interest in drug development: the practices of Merck & Co., Inc.
Hirsch LJ
Sci Eng Ethics; 2002 Jul; 8(3):429-42. PubMed ID: 12353373
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe-An EFPIA View.
Todd I; Faust R; Herrero-Martinez E; Hussain N; Kawinski A; Lennard A; Roux NL; Macdonald J; Mayer M; Palacios R; Dangy-Caye A
Clin Ther; 2023 Nov; 45(11):1142-1147. PubMed ID: 37704457
[TBL] [Abstract][Full Text] [Related]
17. Framework for industry engagement and quality principles for industry-provided medical education in Europe.
Allen T; Donde N; Hofstädter-Thalmann E; Keijser S; Moy V; Murama JJ; Kellner T
J Eur CME; 2017; 6(1):1348876. PubMed ID: 29644135
[TBL] [Abstract][Full Text] [Related]
18. A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
Modi ND; Kichenadasse G; Hoffmann TC; Haseloff M; Logan JM; Veroniki AA; Venchiarutti RL; Smit AK; Tuffaha H; Jayasekara H; Manning-Bennet A; Morton E; McKinnon RA; Rowland A; Sorich MJ; Hopkins AM
BMC Med; 2023 Oct; 21(1):400. PubMed ID: 37872545
[TBL] [Abstract][Full Text] [Related]
19. Data sharing and the evolving role of statisticians.
Manamley N; Mallett S; Sydes MR; Hollis S; Scrimgeour A; Burger HU; Urban HJ
BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):75. PubMed ID: 27410483
[TBL] [Abstract][Full Text] [Related]
20. Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws.
Chimonas S; Rozario NM; Rothman DJ
Health Serv Res; 2010 Feb; 45(1):98-114. PubMed ID: 19840133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]